← Insider Monitor
CorMedix Inc. logo
CRMD

CorMedix Inc.

Nasdaq · Pharmaceutical Preparations

1
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

CorMedix Inc. is a pharmaceutical company that develops and markets DefenCath, an antimicrobial catheter lock solution used to reduce catheter-related bloodstream infections in patients receiving chronic hemodialysis through a central venous catheter.

Industry
Pharmaceutical Preparations
Headquarters
Parsippany, NJ
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
Todisco JosephChief Executive OfficerBuy$391KNov 13, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for CRMD.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable CRMD activity by email

Free alerts for the insider and congressional trades worth watching.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.